Caught on 📸! @bcmgenetics.bsky.social residents and fellows excited to be at the 2025 ACMG Annual Meeting in Los Angeles! 🌴🧬 Networking with brilliant minds and exploring groundbreaking advancements in clinical genetics and genomics. #ACMG2025 #Genetics #BaylorGenetics
Want to hear more? I'll include this project in my talk this afternoon at #ACMG2025 🎤
🗓 Friday, March 21, 1:30 PM PST
📍 Platform Session 8: Genomic Medicine and Education
🎙 Talk: GREGoR: Accelerating Genomics for Rare Diseases
🚨 Big news at #ACMG2025! 🚨
Today we’re announcing global democratization of deidentified allele count + frequency data with population breakdown from the first ~250k short-read WGS in All of Us designed to plug straight into clinical workflows. It is ~1.1 billion unique variants! 🧬💡
🧵 (1/4)
A fun night out at the Crypto Arena with great company for my first basketball game! #ACMG2025 #ACMG25
Photo of Nabsys/Hitachi team members at their booth in the exhibition hall of ACMG25
Here is most of the Nabsys/Hitachi team at #ACMG25 #ACMG2025 booth 328. Great discussions during opening reception tonight. Looking forward to more discussions about Electronic Genome Mapping and structural variants this week. The new version of Nabsys socks are going fast so stop by soon.
Landed in LA for #ACMG2025, ready to nerd out with my gnomies and maybe steal the show in a blockbuster. Lights, camera, action… and clinical genetics! 🎬 😎 🧬
Starting in 3 minutes! Psyched! #ACMG2025
Our co-founders, Norman Ong and Daniel Goldman, are at ACMG 2025.
📍Meet us at Booth 333 to learn how Constantiam Biosciences is advancing precision medicine with cutting-edge solutions for VUS resolution, rare disease diagnosis, and functional genomics.
#ACMGMtg25 #constantiambiosciences #ACMG2025
Nabsys booth at acmg
Nabsys is ready to greet folks at booth 328 at #acmg25 #acmg2025 Some folks need a little more time. See how far Electronic Genome Mapping has advanced at tonight’s opening reception
At #ACMG2025, I’ll present a poster on StrataRisk’s performance in 300 familial hypercholesterolemia (FH) patients from the Mexican FH Registry. Our findings highlight the polygenic burden in FH, especially in patients without rare variants. #CardioGenetics 5/7
Nabsys & Hitachi High-Tech are heading to #ACMG25 next week!
Join me at Booth 328 to learn about our technology, engage with our team, and grab some swag! Connect with our OhmX™ platform and the future of SV analysis.
Stop by to discuss how Nabsys can give your research a jolt with EGM #ACMG2025
Join us at #ACMG2025
We will be showcasing our upcoming rare disease products in our showcase, Advancing Rare Disease Diagnostics, on March 19th at 12:15 PM PST. Lunch will be provided. Register here: lnkd.in/gP847QVR